These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6820919)

  • 1. [Clinical survey on cardiotoxicity of tegafur (FT-207)--compilation of a nationwide survey].
    Kikuchi K; Majima S; Murakami M
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1482-8. PubMed ID: 6820919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
    Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P
    Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on the permeability of FT-207 and 5-FU in primary lung cancer].
    Aogauchi R; Tsubota N; Yamashita C; Yoshikawa K; Ishii N; Nakamura K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):105-10. PubMed ID: 3917651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac side effects of 5-fluorouracil].
    May D; Wandl U; Becher R; Niederle N; Schmidt CG
    Dtsch Med Wochenschr; 1990 Apr; 115(16):618-21. PubMed ID: 2328669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrocardiographic changes in patients with chronic anemia].
    Stanojević M; Stankov S
    Srp Arh Celok Lek; 1998; 126(11-12):461-6. PubMed ID: 9921020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiotoxicity of 5-fluorouracil].
    Pan L; Yang X; Song H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous 12-lead electrocardiographic monitoring in an emergency department chest pain unit: an assessment of potential clinical effect.
    Decker WW; Prina LD; Smars PA; Boggust AJ; Zinsmeister AR; Kopecky SL
    Ann Emerg Med; 2003 Mar; 41(3):342-51. PubMed ID: 12605201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of acute coronary syndrome in patients with normal electrocardiogram performed during presence or absence of chest pain.
    Turnipseed SD; Trythall WS; Diercks DB; Laurin EG; Kirk JD; Smith DS; Main DN; Amsterdam EA
    Acad Emerg Med; 2009 Jun; 16(6):495-9. PubMed ID: 19426294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
    Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
    Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
    Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
    Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of S-1].
    Hirata K; Horikoshi N; Tominaga K; Sohma K; Yamaguchi K; Okazaki M; Furuhata T; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Yamamitsu S; Shirasaka T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():27-35. PubMed ID: 16897969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories].
    Okuda M; Teramoto T; Yoshida H; Sato K; Ushijima Y; Uematsu Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1580-8. PubMed ID: 6820920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group].
    Okuma K; Ariyoshi Y; Wakui A; Ogawa M; Furue H; Niitani H; Shimoyama M; Majima H; Taguchi T; Kimura I
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1143-9. PubMed ID: 2053773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid].
    Murahashi I; Kanbe K; Kaneko K; Honda M; Maeda S; Takahashi E
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1781-8. PubMed ID: 6433803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors.
    Peters GJ; Noordhuis P; Van Groeningen CJ; Giaccone G; Holwerda U; Voorn D; Schrijvers A; Schornagel JH; Beijnen JH; Fumoleau P; Schellens JH
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4072-6. PubMed ID: 15217941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
    Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
    Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.